In light of these data, it is likely that the SDHA-overexpressing aggressive tumors use adipocyte-derived lipids for tumor growth while relying on glutaminolysis to replenish the TCA cycle with carbon intermediates essential for mitochondrial OXPHOS metabolism and biosynthesis pathways to support cancer progression and survival. The gene discussed is SDHA; the disease is cancer.